Quantum-Si Q2 revenue $205k, net loss $25.6M, cash runway into 2026

Quantum-Si Inc

2023-Q2 EPS reported -$0.35 revenue$459,000

Revenue of $205,000 from Platinum instruments and consumables; gross margin 38.0%.
Net loss $25.6M narrowed from $32.4M YoY; adjusted EBITDA negative $22.9M.
Cash and securities $297.2M; reiterates non-GAAP opex flat YoY, runway into 2026.
Added Jeff Keyes as CFO and Johan Denecke as SVP Operations; board members Scott Mendel and Jack Kenny.
Initiated strategic review of R&D programs; expects changes in Q3 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Quantum-Si Inc reported second quarter ended June 30, 2023 results: revenue $205,000, net income $25.6 million. Guidance reaffirmed.

Period: second quarter ended June 30, 2023
Revenue: $205,000
Net income: $25.6 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

“Company”), The Protein Sequencing Company TM , today announced financial results for the second quarter ended June 30, 2023. Second Quarter Highlights ● Recognized revenue of $205,000 in the second quarter of 2023. Exited the quarter with an order backlog of two Platinum TM instruments. ● Strengthened the Board of Directors with the addition of Scott Mendel

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Quantum-Si Inc filing history →

Source: SEC EDGAR

accession 0001140361-23-038175

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.